Chengxi Ren

924 total citations
9 papers, 721 citations indexed

About

Chengxi Ren is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chengxi Ren has authored 9 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Chengxi Ren's work include Prostate Cancer Treatment and Research (5 papers), Fibroblast Growth Factor Research (3 papers) and Epigenetics and DNA Methylation (2 papers). Chengxi Ren is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Fibroblast Growth Factor Research (3 papers) and Epigenetics and DNA Methylation (2 papers). Chengxi Ren collaborates with scholars based in United States. Chengxi Ren's co-authors include Michael Ittmann, Jianghua Wang, Yi Cai, Wendong Yu, Bernard Kwabi‐Addo, David M. Spencer, Benjamin Thompson, Daniel E. Epner, Shan Lu and Yin Liu and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical Pharmacology.

In The Last Decade

Chengxi Ren

9 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengxi Ren United States 8 472 407 222 104 64 9 721
Raquel Esgueva United States 8 454 1.0× 616 1.5× 356 1.6× 119 1.1× 94 1.5× 9 867
Antje Krohn Germany 11 371 0.8× 437 1.1× 213 1.0× 129 1.2× 70 1.1× 17 643
Maria A. Svensson Sweden 14 390 0.8× 341 0.8× 234 1.1× 105 1.0× 61 1.0× 18 629
Mirjam Blattner United States 12 647 1.4× 586 1.4× 338 1.5× 192 1.8× 120 1.9× 15 1.0k
Vijaya L. Dommeti United States 5 821 1.7× 429 1.1× 167 0.8× 161 1.5× 69 1.1× 8 1.0k
Gunther Boysen United Kingdom 11 446 0.9× 493 1.2× 324 1.5× 213 2.0× 118 1.8× 24 779
Dorothee Pflueger United States 8 486 1.0× 330 0.8× 303 1.4× 70 0.7× 75 1.2× 8 687
Lou Savas United States 7 548 1.2× 233 0.6× 173 0.8× 145 1.4× 34 0.5× 10 822
Pasi Koivisto Finland 6 437 0.9× 435 1.1× 217 1.0× 120 1.2× 131 2.0× 7 745
João D. Barros‐Silva Portugal 14 320 0.7× 389 1.0× 206 0.9× 218 2.1× 44 0.7× 22 672

Countries citing papers authored by Chengxi Ren

Since Specialization
Citations

This map shows the geographic impact of Chengxi Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengxi Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengxi Ren more than expected).

Fields of papers citing papers by Chengxi Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengxi Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengxi Ren. The network helps show where Chengxi Ren may publish in the future.

Co-authorship network of co-authors of Chengxi Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Chengxi Ren. A scholar is included among the top collaborators of Chengxi Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengxi Ren. Chengxi Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Cai, Yi, Jianghua Wang, Chengxi Ren, & Michael Ittmann. (2012). Frequent Heterogeneous Missense Mutations of GGAP2 in Prostate Cancer: Implications for Tumor Biology, Clonality and Mutation Analysis. PLoS ONE. 7(2). e32708–e32708. 6 indexed citations
2.
Wang, Jianghua, Yi Cai, Longjiang Shao, et al.. (2010). Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4. Cancer Research. 71(4). 1325–1333. 66 indexed citations
3.
Kwabi‐Addo, Bernard, Chengxi Ren, & Michael Ittmann. (2009). DNA methylation and aberrant expression of Sprouty1 in human prostate cancer. Epigenetics. 4(1). 54–61. 18 indexed citations
4.
Wang, Jianghua, Yi Cai, Wendong Yu, et al.. (2008). Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts. Cancer Research. 68(20). 8516–8524. 130 indexed citations
5.
Wang, Jianghua, Wendong Yu, Yi Cai, Chengxi Ren, & Michael Ittmann. (2008). Altered Fibroblast Growth Factor Receptor 4 Stability Promotes Prostate Cancer Progression. Neoplasia. 10(8). 847–856. 78 indexed citations
6.
Wang, Jianghua, Yi Cai, Chengxi Ren, & Michael Ittmann. (2006). Expression of Variant TMPRSS2/ERG Fusion Messenger RNAs Is Associated with Aggressive Prostate Cancer. Cancer Research. 66(17). 8347–8351. 297 indexed citations
7.
Lu, Shan, Chengxi Ren, Yin Liu, & Daniel E. Epner. (2006). PI3K-Akt signaling is involved in the regulation of p21WAF/CIP expression and androgen-independent growth in prostate cancer cells. International Journal of Oncology. 28(1). 245–51. 38 indexed citations
8.
Wang, Jianghua, Benjamin Thompson, Chengxi Ren, Michael Ittmann, & Bernard Kwabi‐Addo. (2005). Sprouty4, a suppressor of tumor cell motility, is downregulated by DNA methylation in human prostate cancer. The Prostate. 66(6). 613–624. 73 indexed citations
9.
Lu, Shan, George L. Chen, Chengxi Ren, Bernard Kwabi‐Addo, & Daniel E. Epner. (2003). Methionine restriction selectively targets thymidylate synthase in prostate cancer cells. Biochemical Pharmacology. 66(5). 791–800. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026